United Kingdom · Question · Written question
UIN 11721
Pancreatic Cancer: Pancreatic Enzyme Replacement Therapy
Introduced
7 June 2021
Last action
10 June 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
10 June 2021
Summary
To ask the Secretary of State for Health and Social Care, how many and what proportion of pancreatic cancer patients in England were prescribed pancreatic enzyme replacement therapy in (a) 2015, (b) 2016, (c) 2017, (d) 2018 and (e) 2019.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
7 June 2021
Written question
To ask the Secretary of State for Health and Social Care, how many and what proportion of pancreatic cancer patients in England were prescribed pancreatic enzyme replacement therapy in (a) 2015, (b) 2016, (c) 2017, (d) 2018 and (e) 2019.
Source: Commons
10 June 2021
Answer
Information on the proportion of pancreatic cancer patients in England prescribed with pancreatic enzyme replacement therapy (PERT) is not available in the format requested.No assessment has been made of rates of prescription of PERT, though we recognise ...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-06-07/11721
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1330306
- uk · wq-1330306 · source updated 10 June 2021